T cell lymphoma presented by Dr Samar Issa

This week LBC’s Winter-Spring Webinar series held the 3rd of our 6 lymphoma webinars, ‘T cell lymphoma’ presented by Dr Samar Issa. Non-Hodgkin lymphomas caused by T-cell lymphocytes are rare, representing about 15% of all Non Hodgkin lymphomas.

Dr Issa gives a thorough breakdown of the 4 main sub-types of T cell lymphoma, the current treatment, as well as new emerging targeted treatment. Dr Issa is Consultant haematologist and Clinical Head of the Lymphoma Service at Middlemore Hospital, Auckland. Dr Issa is an active member of a number of scientific groups; is the founding chair of the Lymphoma Network of New Zealand and the founding clinical director of the Middlemore Tissue Bank. She has multiple research publications and is the primary investigator on several local and international lymphoma clinical trials.

The opinions expressed in the comments on this video are those of the individual typing them and not necessarily of Leukaemia & Blood Cancer New Zealand. Comments deemed offensive will be deleted.